Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Histone deacetylase 9-mediated phenotypic transformation of vascular smooth muscle cells is a potential target for treating aortic aneurysm/dissection.

doi: 10.1016/j.biopha.2024.116396

Figure Lengend Snippet: Fig. 7. HDAC9 expression is elevated in AAD aortic tissue. Mechanistically, HDAC9 binds to the promoter regions of SOD2 and IGFBP3, transcriptionally suppressing their expression, forming the HDAC9-SOD2/IGFBP3 axis, regulating the phenotypic transformation, proliferation, apoptosis, and invasion of VSMCs during the process of AAD occurrence. TMP195 reverses this process by inhibiting HDAC9, suppressing the formation and development of AAD.

Article Snippet: TMP195 (50 mg/kg; Cat#T3983; TargetMol) or a control solvent (5% DMSO + 30% PEG300 + 5% Tween-80 + 60% Saline) was administered daily via intraperitoneal injection daily for 4 weeks.

Techniques: Expressing, Transformation Assay

Journal: Redox Biology

Article Title: N -butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity

doi: 10.1016/j.redox.2025.103835

Figure Lengend Snippet: The protective effects of the candidate compounds and the positive drug NBP on OGD/R induced SH-SY5Y cells and primary hippocampal neurons. (A) The protective effects of 8a-8e , 8j , 8m-8o and NBP on the OGD/R induced SH-SY5Y cell model. (B) The effects of 8a-8e , 8j , 8m-8o and NBP on LDH release. (C) The cytotoxicity of 8a , 8b , 8d , 7m , TMP and NBP on the normal primary hippocampal neurons. (D) The protective effects of 8a , 8b , 8d , 7m , TMP and NBP on OGD/R induced primary hippocampal neurons. Data are presented as mean ± SD of each group (n = 3). ### P < 0.001 vs control group, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs OGD/R group, & P < 0.05, && P < 0.01, &&& P < 0.001 vs NBP group.

Article Snippet: NBP and TMP (Target Mol.

Techniques: Control

Journal: Optics Express

Article Title: Enhanced nonlinear optical responses in donor-acceptor ionic complexes via photo induced energy transfer

doi: 10.1364/oe.18.025928

Figure Lengend Snippet: Fig. 1. (a) Chemical structure of TMPyP (P+). (b) Chemical structure of T790 (P-). (c) Schematic representation of Au + P+ complex. (d) Schematic representation of GO + P+ complex.

Article Snippet: The positively-charged TMPyP (meso-Tetra (N-methyl-4-pyridyl) porphine tetra tosylate) (P+), and negatively charged T790 (meso-Tetra (4-carboxyphenyl) porphine) (P-) porphyrin were purchased from the Frontier Scientific and their structures are displayed in Fig. 1.

Techniques:

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Differential interaction of C1 domains with p23/Tmp21. (A) Schematic representation of C1εa-b, C1εa, C1εb, C1ζ, or C1β2-ch domain fused to pLexA. (B) EGY48 yeast (containing 8op-LacZ vector) was cotransformed with pLexA encoding C1εa-b, C1εa, C1εb, C1ζ, or C1β2-ch domain, and pB42AD-HA-tagged p23/Tmp21 (aa 108-208). Assay of β-galactosidase activity on induction (top) or no-induction (bottom) plates was carried out 72 h after transformation. Gal/Raf, galactosidase/raffinose. (C) Assay of β-galactosidase activity in liquid cultures using ONPG as a substrate. Results were expressed as mean ± SD (n = 3). (D) GFP-PKCεC1b domain localizes in the perinuclear region. HeLa cells were transfected with pEGFP-C1εa, C1εb, C1ζ, or C1β2-ch. Forty-eight hours later, cells were fixed and localization examined by confocal microscopy. Bar, 10 μm. All experiments have been performed at least three times with similar results.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Plasmid Preparation, Activity Assay, Transformation Assay, Transfection, Confocal Microscopy

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Colocalization of GFP-fused PKCε C1b and β2-chimaerin C1 domains with p23/Tmp21. HeLa cells were cotransfected with pEGFP-fused C1εa, C1εb, C1ζ, or C1β2-ch (or empty vector) and V5-tagged full-length pcDNA3-p23/Tmp21. Forty-eight hours later, cells were fixed and stained with an anti-V5 antibody, and localization was examined by confocal microscopy. Colocalization images and Pearson's r (Rr) were generated by ImageJ. Similar results were observed at least in three independent experiments. Bar, 10 μm.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Plasmid Preparation, Staining, Confocal Microscopy, Generated

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Differential interaction of PKCε and β2-chimaerin with p23/Tmp21. (A and B) COS-1 cells were transfected with either pEBG (empty vector) or pEBG-p23/Tmp21. Twenty-four hours later, cells were infected with either HA-β2-chimaerin adenovirus (multiplicity of infection [MOI], 10 plaque-forming units [pfu]/cell) (A) or PKCε adenovirus (MOI = 3 pfu/cell) (B). After 24 h, cells were treated with PMA (1 μM) or vehicle for 30 min in the presence of the PKC inhibitor GF109203X (5 μM) and lysed. GST or GST-p23/Tmp21 proteins were precipitated with glutathione-Sepharose 4B beads, and associated HA-β2-chimaerin was detected by Western blot using an anti-HA antibody. Left, representative experiments. Right, densitometric analysis of three individual experiments, expressed as fold change relative to GST-p23/Tmp21 in the absence (A) or presence (B) of PMA. (C) HeLa cells were cotransfected with either pEGFP-PKCε or pEGFP-β2-chimaerin and pcDNA3.1/V5-p23/Tmp21 (full length). Forty-eight hours later, cells were treated with PMA (1 μM) or vehicle for 30 min, fixed, and stained with an anti-V5 antibody, and localization examined by confocal microscopy. Top, green fluorescence from GFP-PKCε or GFP-β2-chimaerin; middle, red fluorescence from pcDNA3.1/V5-p23/Tmp21; bottom, overlapped images. Colocalization images and Pearson's r (Rr) were generated by ImageJ. Similar results were obtained in three additional experiments. Bar, 10 μm.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Transfection, Plasmid Preparation, Infection, Western Blot, Staining, Confocal Microscopy, Fluorescence, Generated

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: p23/Tmp21 RNAi depletion impairs perinuclear β2-chimaerin translocation. (A) Expression of p23/Tmp21 in HeLa cells stably expressing different p23/Tmp21 shRNAs (shRNA#1, shRNA#2, and shRNA#3) or control cells. (B) Cells were transfected with pEGFP-β2-chimaerin and 48 h later treated with PMA (3 μM) in the presence of GF109203X (5 μM). Time-lapse images of β2-chimaerin translocation in living cells were captured at different times after PMA treatment. Perinuclear and periphery translocation were marked with arrows. Similar results were observed in three individual experiments. Bar, 10 μm.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Translocation Assay, Expressing, Stable Transfection, shRNA, Control, Transfection

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Glu227 and Leu248 residues in the β2-chimaerin C1 domain are required for the interaction with p23/Tmp21. (A) EGY48 yeast (containing 8op-LacZ vector) was cotransformed with pLexA-β2-chim-C1 (E227G), pLexA-β2-chim-C1 (L248A), pLexA-β2-chim-C1 (E227G/L248A), or pLexA-β2-chim-C1 (C246A), and pB42AD-HA-tagged p23/Tmp21 (aa 108-208). Assay of β-galactosidase activity on induction (top) or no-induction (bottom) plates was carried out 72 h after transformation. Gal/Raf, galactosidase/raffinose. (B) COS-1 cells were cotransfected with either pEBG (empty vector) or pEBG-p23/Tmp21 and GFP vector, GFP-β2-chimaerin (wt), GFP-β2-chimaerin (E227G/L248A) or GFP-β2-chimaerin (C246A). After 24 h, cells were lysed. GST or GST-p23/Tmp21 proteins were precipitated with glutathione-Sepharose 4B beads and associated GFP-fused proteins detected by Western blot using an anti-GFP antibody. Left, representative experiments. Right, densitometric analysis of three individual experiments, expressed as fold change relative to GST-p23/Tmp21 bound β2-chimaerin (wt).

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Plasmid Preparation, Activity Assay, Transformation Assay, Western Blot

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Colocalization studies of β2-chimaerin mutants and p23/Tmp-21. HeLa cells were cotransfected with pEGFP-β2-chim (wt), pEGFP-β2-chim (C246A), pEGFP-β2-chim (E227G), pEGFP-β2-chim (L248A), or pEGFP-β2-chim (E227G/L248A) and V5-tagged pcDNA-p23/Tmp21. Forty-eight hours later, cells were treated with PMA (3 μM) or vehicle for 30 min in the presence of GF 109203X (5 μM). Cells were then washed and visualized by confocal microscopy. Left, green fluorescence from GFP-β2-chimaerin (wild-type or mutants); middle, red fluorescence from pcDNA3.1/V5-p23/Tmp21; right, overlapped images. Far right, colocalization images generated by ImageJ. Similar results were obtained in three different experiments. Bar, 10 μm.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Confocal Microscopy, Fluorescence, Generated

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Identification of the β2-chimaerin C1 domain interacting region in p23/Tmp21. EGY48 yeast (containing 8op-LacZ vector) was cotransformed with pLexA-fused α1-chimaerin (aa 1–147) and pB42AD-HA–tagged p23/Tmp21 truncated mutants. (A) Top, schematic representation of p23/Tmp21 constructs used in the yeast two-hybrid assay. Middle, chimaerin expression in yeast lysates, as determined by Western blot using an anti-pLexA antibody; and expression of p23/Tmp21 truncated proteins in yeast lysates using an anti-HA antibody. Bottom, assay of β-galactosidase activity on induction or no-induction plates, carried out 72 h after transformation. Gal/Raf, galactosidase/raffinose. (B) COS-1 cells were transfected with either pEBG (empty vector) or pEBG-p23/Tmp21, and infected with a HA-β2-chimaerin adenovirus (multiplicity of infection [MOI] = 10 plaque-forming units [pfu]/cell). Thirty-six hours later, GST or GST-p23/Tmp21 proteins were precipitated with glutathione-Sepharose 4B beads and associated HA-β2-chimaerin detected by Western blot using an anti-HA antibody. Top, schematic representation of GST-p23/Tmp21 constructs used in the coprecipitation assays. Middle, expression of GST-p23/Tmp21 or its mutants and HA-β2-chimaerin in cell lysates. Bottom, associated HA-β2-chimaerin and GST-p23/Tmp21 or its mutants in pull-down assay were detected by Western blot using anti-HA and anti-GST antibody respectively. Similar results were observed in two additional experiments.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Plasmid Preparation, Construct, Y2H Assay, Expressing, Western Blot, Activity Assay, Transformation Assay, Transfection, Infection, Pull Down Assay

Journal: Molecular Biology of the Cell

Article Title: p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains

doi: 10.1091/mbc.E09-08-0735

Figure Lengend Snippet: Disruption of β2-chimaerin-p23/Tmp21 interaction leads to enhanced β2-chimaerin Rac-GAP activity. (A) COS-1 cells were transfected with pEGFP, pEGFP-β2-chimaerin (wt), or pEGFP-β2-chimaerin (E227G/L248A). Forty-eight hours later, Rac-GTP levels were assayed using a GST-PBD pull-down assay. (B) Densitometric analysis of Rac-GTP levels relative to control (GFP alone). Data are expressed as mean ± SE of five independent experiments. *p < 0.05 between GFP versus GFP-β2-chim (wt); **p < 0.01 between GFP-β2-chim (wt) versus GFP-β2-chim (E227D/L248A). #p < 0.01 between GFP-β2-chim (wt) (−PMA) versus GFP-β2-chim(wt) (+PMA). (C) Western blots show GFP, GFP-β2-chim (wt) and GFP-β2-chim (E227D/L248A) protein expression.

Article Snippet: The following primary antibodies were used: anti-pLexA (Santa Cruz Biotechnology, Santa Cruz, CA), anti-β-actin (Sigma-Aldrich), anti-V5 (Invitrogen), anti-p23/Tmp21 (ProSci, Poway, CA), anti-GST, anti-hemagglutinin (HA), anti-green fluorescent protein (GFP) (Covance, Emeryville, CA), anti-Rac1 (Millipore, Billerica, MA), anti-PKCε (Cell Signaling Technology, Danvers, MA), and anti-GS28 (BD Biosciences, San Jose, CA).

Techniques: Disruption, Activity Assay, Transfection, Pull Down Assay, Control, Western Blot, Expressing

Journal: Oncotarget

Article Title: Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.

doi: 10.18632/oncotarget.14809

Figure Lengend Snippet: Figure 1: The C-termini of transmembrane 4 L six family members 1, 4, and 5 had similar effects on cell growth in 2D culture condition. A. Alignment of the C-terminal sequences of TM4SF1, TM4SF4, and TM4SF5 showed differences in the sequences around their cytosolic tails. B. Schemes of the wild-type (WT) and deletion or chimeric mutants used in the study. C. mRNA levels of tm4sf1, tm4sf4, and tm4sf5 in different colon cancer cells. D. Expression levels of the constructs (protein in left panel and mRNA in right panel) in stable HCT-116 cells. Within the TM4SF1 backbone (e.g., WT TM4SF1 [1WT], C-terminus-deleted TM4SF1 [1ΔC], and a chimera with the TM4SF5 C-terminus linked to the other parts of TM4SF1 [1C5]), the expression levels were similar each other. As for the TM4SF4 and TM4SF5 backbone, their expression levels were also comparable within each backbone. E. Growth of stable cells was monitored (from day 1 to day 2 after seeding) using an MTT assay, as described in the Materials and Methods. Values shown are the mean ± standard deviation (SD). *, **, and *** denote statistically significant differences at p <0.05, 0.005, or 0001, respectively, and ‘ns’ indicates a nonsignificant difference at p ≥ 0.05, by the ANOVA with Tukey’s post-tests. The data shown represent three independent experiments.

Article Snippet: TM4SF1 and TM4SF4 cDNAs were purchased from Origene (Rockville, MD, USA).

Techniques: Expressing, Construct, MTT Assay, Standard Deviation

Journal: Oncotarget

Article Title: Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.

doi: 10.18632/oncotarget.14809

Figure Lengend Snippet: Figure 3: TM4SF1 and TM4SF5 but not TM4SF4 promoted enhanced transwell migration, and the TM4SF5 C-terminus could replace the pro-migratory effect of the TM4SF1 C-terminus. A. Cells incubated with 1% BSA-DMEM for 2 h were loaded (105 cells/condition) to the transwell chambers, the bottom sides of which were pre-coated with collagen I (10 μg/ml). After 10 h, cells that had migrated through the transwell chambers were stained with 5% crystal violet, and images were then acquired randomly; representative images are shown. B. The number of migrated cells from 10 random images per experimental condition were determined using an Image J software based on the intensity of staining. Values shown are the mean ± SD. Immunoblots for phospho-Tyr416 in c-Src and c-Src were performed using whole-cell lysates of the stable cells. *, **, and *** denote statistically significant differences at p <0.05, 0.005, or 0001, respectively, and ‘ns’ indicates a nonsignificant difference at p ≥ 0.05 by the ANOVA with Tukey’s post-tests. The data shown represent three independent experiments.

Article Snippet: TM4SF1 and TM4SF4 cDNAs were purchased from Origene (Rockville, MD, USA).

Techniques: Migration, Incubation, Staining, Software, Western Blot

Journal: Oncotarget

Article Title: Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.

doi: 10.18632/oncotarget.14809

Figure Lengend Snippet: Figure 5: TM4SF5 and its C-terminus could positively replace the effects of TM4SF1 and TM4SF4 to promote invasive dissemination from spheroids embedded in 3D collagen I gels. A. Scheme of the ‘on-top’ 3D ECM-surrounded culture environment, in which the cells (red) were mixed with a lower concentration (yellow-pink) of collagen I gel (0.2 mg/ml) and overlaid on the bottom dense layer with collagen I gel at a higher concentration (blue, 2 mg/ml) that was previously solidified. B to E. Representative images of the starting (each left) and ending (each right) points of the live-imaged spheroids in each condition were shown (B and E). The two-tailed unpaired Student’s t-test was used for the analysis in (B). * denotes statistically a significant difference at p <0.05, but ‘ns’ insignificantly at p ≥0.05. The dissemination initiation times (C) or numbers of cells disseminating (D) from the spheroids were measured during the live- imaging for 36 (C) or 24 (D) h and are presented in the graph as mean ± SD values. White arrow heads depict the disseminating cells (B). Immunoblotting for phospho-Tyr397 in FAK and FAK was performed by using the whole cell lysates prepared from the spheroids in 3D collagen I gels. PP2 or PP3 (10 μM) was added to the gels during the embedding processes, before 24 h live-imaging (E).

Article Snippet: TM4SF1 and TM4SF4 cDNAs were purchased from Origene (Rockville, MD, USA).

Techniques: Concentration Assay, Two Tailed Test, Imaging, Western Blot

Journal: EMBO Reports

Article Title: Sulf1 regulates inflammation via modulation of TGF-β dependent epicardial activation

doi: 10.1038/s44319-026-00910-5

Figure Lengend Snippet: ( A ) 4 dpci DMSO-treated and TGF-β inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .

Article Snippet: For the TGF-β inhibitor experiment, fish were incubated in system water supplemented with TGF-β inhibitor (Cat. no. SB431542, 50 mg BOC Sciences) or DMSO at a concentration of 10 μM per fish starting 1 day prior to cryoinjuries until 4 dpci when the hearts were extracted.

Techniques: Staining, Quantitative RT-PCR, Analysis, Control, MANN-WHITNEY

Journal: Cell Death & Disease

Article Title: Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity

doi: 10.1038/s41419-024-07215-2

Figure Lengend Snippet: a Representative images of colony formation in multiple human colorectal cancer cell lines HCT15, LST174T, RKO, SW620, NCI-H508, Caco2, and mouse colon cell line CT26 treated with the indicated concentrations of TMPyP4. b The line graph represents the relative colony formation of colorectal cancer cells treated with the indicated concentrations of TMPyP4. c Cell viability of colorectal cancer cells and normal cells was measured with the CCK8 assay. Cells were treated with TMPyP4 for 72 h. d , e Cells were treated with 4 μM or 8 μM TMPyP4 for 48 h. Then, the proportion of apoptotic cells was detected using annexin V-propidium iodide-based flow cytometry. Values are represented as mean ± SD, **** p ≤ 0.0001, by multiple t-tests. f , g Cell cycle analysis of colorectal cancer cells treated with or without TMPyP4 for 24 h. Cellular DNA content was determined by propidium iodide staining and flow cytometry. h, i The tumor size ( h ) and tumor weight ( i ) of nude mice bearing SW620 colorectal tumors treated with vehicle or 30 mg/kg TMPyP4. n = 6 mice for both groups. Values are represented as mean ± SD, **** p ≤ 0.0001, by unpaired t-test. j , k The tumor size ( j ) and tumor weight ( k ) of nude mice treated with vehicle or 30 mg/kg TMPyP4 in the PDX model. n = 6 mice for both groups. Values are represented as mean ± SD, **** p ≤ 0.0001, by two-way ANOVA ( h , j ) or unpaired t-test ( i , k ).

Article Snippet: TMPyP4 was purchased from MCE (HY-108477).

Techniques: CCK-8 Assay, Flow Cytometry, Cell Cycle Assay, Staining

Journal: Cell Death & Disease

Article Title: Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity

doi: 10.1038/s41419-024-07215-2

Figure Lengend Snippet: a Experimental treatment strategy for tumor growth inhibition in a syngeneic mouse tumor model. When tumors were palpable, mice were treated with vehicle or 30 mg/kg TMPyP4 three times a week (days 0, 3, 6). b , c The tumor size and tumor weight of BALB/C mice bearing CT26 colon cancer treated with vehicle or 30 mg/kg TMPyP4. n = 6 mice for both groups. d , e The tumor size and tumor weight of C57BL/6 mice bearing MC38 colon cancer treated with vehicle or 30 mg/kg TMPyP4. n = 6 mice for both groups. ( f , g ) The tumor size and tumor weight of nude mice bearing MC38 colon cancer treated with vehicle or 30 mg/kg TMPyP4. n = 6 mice for both groups. h, i Tumor growth inhibition comparison between C57BL/6 and nude mice after TMPyP4 treatment. j – p Graphs show the frequencies of CD45 + cells ( j ), CD3 + T cells ( k ), CD8 + T cells ( l ), DCs ( m ), CD4 + T cells ( n ), NK cells ( o ), and B cells ( p ) in CT26 tumors after TMPyP4 treatment or vehicle control treatment. q – w Graphs show the frequencies of CD45 + cells ( q ), CD3 + T cells ( r ), CD8 + T cells ( s ), DCs ( t ), CD4 + T cells ( u ), NK cells ( v ), and B cells ( w ) in MC38 tumors after TMPyP4 treatment or vehicle control treatment. ns : not significant, * p ≤ 0.05, *** p ≤ 0.001, **** p ≤ 0.0001, by two-way ANOVA ( b , d , f ), or by untailed t-tests ( c , e , g – w ).

Article Snippet: TMPyP4 was purchased from MCE (HY-108477).

Techniques: Inhibition, Comparison, Control

Journal: Cell Death & Disease

Article Title: Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity

doi: 10.1038/s41419-024-07215-2

Figure Lengend Snippet: a – h Representative FACS plots and quantification of IFNγ expression ( a , b ), TNFα expression ( c , d ), perforin expression ( e , f ), and PD-1 expression ( g , h ) among CD8 + T cells in MC38 tumors with TMPyP4 treatment or vehicle control treatment. i – l Surface expression of CD80, CD86, and MHC-I on DCs was determined by FACS. Values are represented as mean ± SD, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001, by untailed t-tests ( b , d , f , h , l ).

Article Snippet: TMPyP4 was purchased from MCE (HY-108477).

Techniques: Expressing, Control

Journal: Cell Death & Disease

Article Title: Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity

doi: 10.1038/s41419-024-07215-2

Figure Lengend Snippet: a , b GSEA of the signaling pathway, including regulation of double-strand break repair and DNA double-strand break response in MC38 tumors with TMPyP4 treatment or vehicle control treatment. c Mean tail moment of the HCT116 and MC38 cells treated with or without TMPyP4 in a comet assay. d Quantification of foci/nucleus of γ-H2AX immunofluorescence staining of HCT116 and MC38 cells treated with or without TMPyP4. e Statistical analysis of γ-H2AX in MC38 tumors with TMPyP4 treatment or vehicle control treatment. f Representative images of G4 and γ-H2AX immunofluorescence staining of HCT116 treated with plasmids pCDNA3.1 or PIF1-pCDNA3.1 in the presence of TMPyP4. g , h Quantification of foci/nucleus of G4 and γ-H2AX in ( f ). i , j Western blots of p-TBK1, TBK1, p-STING, STING, and GAPDH in colorectal cancer cells with the indicated concentrations of TMPyP4. k – m RNA levels of Ccl5, Cxcl10, and Ifn-β were detected in CT26 and MC38 treated with or without TMPyP4 for 48 h. n Representative immunostainings of CD8, CD11c, and P-STING in paraffin sections of MC38 tumors with TMPyP4 treatment or vehicle control treatment (CD8 [green], CD11c [orange], P-STING [red], DAPI [blue]) (magnification ×200). o , p The tumor size and tumor weight of C57BL/6 mice bearing indicated MC38 colon cancer treated with vehicle or 30 mg/kg TMPyP4. n = 5 mice for both groups. Values are represented as mean ± SD, ns : not significant, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, by untailed t-tests ( c , d , e , g , h , k , l , m ), or by two-way ANOVA ( g ).

Article Snippet: TMPyP4 was purchased from MCE (HY-108477).

Techniques: Control, Single Cell Gel Electrophoresis, Immunofluorescence, Staining, Western Blot

Journal: Cell Death & Disease

Article Title: Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity

doi: 10.1038/s41419-024-07215-2

Figure Lengend Snippet: a – f Tumor growth of vehicle, TMPyP4 alone (30 mg/kg), anti-PD1 alone (200 μg/body), and TMPyP4 plus anti-PD1 groups in BALB/C mice injected with CT26 cells ( a – c ) or C57BL/C mice injected with MC38 cells ( d – f ). n = 4 mice for each group. g , h The frequencies of CD8 + T cells in CT26 ( g ) and MC38 ( h ) tumors after vehicle, TMPyP4 alone (30 mg/kg), anti-PD1 alone (200 μg/body), and TMPyP4 plus anti-PD1 groups treatment. Values are represented as mean ± SD, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, by two-way ANOVA ( b , e ), or by untailed t-tests ( c , f , g , h ). i Relationship between G4 expression and immunotherapy efficacy in colorectal patients. j The overview of the study.

Article Snippet: TMPyP4 was purchased from MCE (HY-108477).

Techniques: Injection, Expressing